B. Lynne Parshall, Director at IONIS PHARMACEUTICALS INC (IONS), sold 29,250 shares at $51.49 ($1.5M) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.42 | 10,750 | $542K | 36.3% |
| 2 | $51.49 | 9,250 | $476K | 31.9% |
| 3 | $51.49 | 9,250 | $476K | 31.9% |
| Total | $51.10 avg | 29,250 | $1.5M | 100% |
| Filing → |
| IONS | SELL | 2026-04-17 | $381K | — | Filing → |
| CYTK | SELL | 2026-03-02 | $306K | — | Filing → |
| IONS | SELL | 2026-02-13 | $414K | — | Filing → |